In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Veterinary drug play Aratana Therapeutics is among the potential solid performers next year.
Pfizer may not be the best investment in coming months, as doubts surface about the company's near-term prospects in the absence of M&A.
An update on some recent small biotech recommendations.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.